Article info
PDFPostScript
Letter
Comparison of immune checkpoint inhibitor-related neuropathies among patients with neuroendocrine and non-neuroendocrine tumours
- Correspondence to Dr Divyanshu Dubey, Department of Neurology, Mayo Clinic, Rochester 55905, Minnesota, USA; Dubey.Divyanshu{at}mayo.edu
Citation
Comparison of immune checkpoint inhibitor-related neuropathies among patients with neuroendocrine and non-neuroendocrine tumours
Publication history
- Received February 11, 2021
- Revised April 26, 2021
- Accepted April 28, 2021
- First published May 26, 2021.
Online issue publication
February 19, 2024
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.